Carlos Miguel Angelats-Romero
Research Subjects
Carlos Miguel Angelats-Romero has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Gomez-Sanchez
Departamento de Pediatría, Hospital Universitario Francesc de Borja, Gandia, Valencia, Spain
2 shared publications - Jose Miguel Sequí-Sabater
Rheumatology Department, La Ribera University Hospital, Alzira, Spain; Rheumatology Department, La Fe University and Polytechnic Hospital, Valencia, Spain; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
2 shared publications - José Miguel Sequí Canet
Spanish Association of Paediatrics, FISABIO, 46701 Gandia, Spain
2 shared publications A. Lora-Martin
Servicio de Urgencias Pediátricas, Hospital Universitario Francesc de Borja, Gandía, Spain; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia, Spain
1 shared publicationBeatriz Azkunaga-Santibañez
Servicio de Urgencias de Pediatría, Hospital Universitario Cruces, Bilbao, Spain
1 shared publication- Elena Felipe Almira
Departamento de Pediatría, Hospital Universitario Francesc de Borja, Gandia, Valencia, Spain
1 shared publication
Latest Publications
- 19 March 2026
- Published by Elsevier in Acta Otorrinolaringologica (English Edition)
- Vol. 77 (4) , 512344
Is it useful to repeat the hearing screening test before hospital discharge?
- 19 March 2026
- Published by Elsevier in Acta Otorrinolaringologica (English Edition)
- Vol. 77 (4) , 512344
Is it useful to repeat the hearing screening test before hospital discharge?
- Open Access
- 15 July 2025
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 103 (1) , 503841
Divergences in recommendations between the toxicological information service and two reference resources in pediatric poisoning management
- 15 July 2025
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 103 (1) , 503841
Open AccessDivergences in recommendations between the toxicological information service and two reference resources in pediatric poisoning management
- Open Access
- 27 May 2025
- Published by AccScience Publishing in Journal of Clinical and Translational Research
- Vol. 11 (4) , 8416
Gender differences in otoacoustic emissions test pass rates: Evidence from a general population and twin study
Background: Evoked otoacoustic emissions are one of the most widely employed techniques in assessing neonatal hearing. However, several factors may influence the outcomes of this test. One such factor is gender, as previous research has shown that females tend to exhibit a greater otoacoustic response than males. Aim: This study evaluates whether gender influences the pass rate of the otoacoustic emissions test in neonatal hearing screening, using data from both the general population and twin pairs. Methods: Data from the Newborn Hearing Screening (NHS) program and infant gender were collected between 2002 and 2023 from 22,825 healthy newborns in the maternity or neonatal ward. Of these, 586 cases were from twin pregnancies. A separate analysis was conducted for twins, distinguishing between same-sex and opposite-sex pairs. Results: A highly significant difference (p<0.0001) in NHS pass rates was observed in favor of females, who demonstrated better responses to the test. In the twin subgroup, analysis of the 112 discordant-sex pairs with differing test outcomes revealed a statistically significant result (p<0.023), further supporting the positive effect of female sex on successfully passing the hearing screening test. Conclusion: Female newborns exhibit stronger otoacoustic emission responses and higher pass rates in the NHS test compared to male newborns. These gender-based variations in otoacoustic emission responses may have important implications for the NHS, as otoacoustic emissions are a commonly used screening tool in neonatal hearing assessment. Relevance for patients: Recognizing and accounting for these gender-based differences in otoacoustic emission responses may inform modifications to screening program protocols, potentially improving the identification of hearing impairment in newborns.
- 27 May 2025
- Published by AccScience Publishing in Journal of Clinical and Translational Research
- Vol. 11 (4) , 8416
Open AccessGender differences in otoacoustic emissions test pass rates: Evidence from a general population and twin study
Background: Evoked otoacoustic emissions are one of the most widely employed techniques in assessing neonatal hearing. However, several factors may influence the outcomes of this test. One such factor is gender, as previous research has shown that females tend to exhibit a greater otoacoustic response than males. Aim: This study evaluates whether gender influences the pass rate of the otoacoustic emissions test in neonatal hearing screening, using data from both the general population and twin pairs. Methods: Data from the Newborn Hearing Screening (NHS) program and infant gender were collected between 2002 and 2023 from 22,825 healthy newborns in the maternity or neonatal ward. Of these, 586 cases were from twin pregnancies. A separate analysis was conducted for twins, distinguishing between same-sex and opposite-sex pairs. Results: A highly significant difference (p<0.0001) in NHS pass rates was observed in favor of females, who demonstrated better responses to the test. In the twin subgroup, analysis of the 112 discordant-sex pairs with differing test outcomes revealed a statistically significant result (p<0.023), further supporting the positive effect of female sex on successfully passing the hearing screening test. Conclusion: Female newborns exhibit stronger otoacoustic emission responses and higher pass rates in the NHS test compared to male newborns. These gender-based variations in otoacoustic emission responses may have important implications for the NHS, as otoacoustic emissions are a commonly used screening tool in neonatal hearing assessment. Relevance for patients: Recognizing and accounting for these gender-based differences in otoacoustic emission responses may inform modifications to screening program protocols, potentially improving the identification of hearing impairment in newborns.